chr20-62260071-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000313733.9(OSBPL2):c.128G>T(p.Arg43Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,613,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000313733.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBPL2 | NM_144498.4 | c.128G>T | p.Arg43Met | missense_variant | 3/14 | ENST00000313733.9 | NP_653081.1 | |
OSBPL2 | NM_014835.5 | c.92G>T | p.Arg31Met | missense_variant | 3/14 | NP_055650.1 | ||
OSBPL2 | NM_001363878.2 | c.-239G>T | 5_prime_UTR_variant | 3/15 | NP_001350807.1 | |||
OSBPL2 | NM_001278649.3 | c.-184-3545G>T | intron_variant | NP_001265578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBPL2 | ENST00000313733.9 | c.128G>T | p.Arg43Met | missense_variant | 3/14 | 1 | NM_144498.4 | ENSP00000316649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251448Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135900
GnomAD4 exome AF: 0.000115 AC: 168AN: 1461746Hom.: 0 Cov.: 30 AF XY: 0.000111 AC XY: 81AN XY: 727190
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 10, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1299987). This variant has not been reported in the literature in individuals affected with OSBPL2-related conditions. This variant is present in population databases (rs143116125, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with methionine, which is neutral and non-polar, at codon 43 of the OSBPL2 protein (p.Arg43Met). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at